Founder pipeline · Co-investment · Founder support
We find founders traditional capital does not yet know how to see.
Infectious connects exceptional founders with aligned investors who care about the human behind the company. We back lived insight, AI leverage, community trust and founder resilience as underpriced sources of venture advantage.
What Infectious is becoming
An emerging founder pipeline, co-investment and founder-support platform for the AI era.
We look for founders whose lived experience gives them unusual insight into urgent human problems. Then we help surround them with the right capital, care, expertise and network.
We are not here to make founders more extractable. We are here to help the right founders become more investable without losing the soul of the work.
The Thesis
The next edge is lived insight.
AI has changed what it takes to build. Small teams can now create, test and scale products faster than ever before. As the cost of execution falls, the real advantage shifts towards founders with deep proximity to the problem, trust with the people they serve, and the resilience to build something meaningful through uncertainty.
Traditional venture often misses these founders because they do not always arrive through familiar networks, polished decks or predictable patterns.
Infectious exists to see them earlier.
What We Back
Human flourishing infrastructure for the AI era.
We are interested in founders building in areas such as:
Care and caring infrastructure.
Disability and neurodivergence.
Mental wellbeing and emotional capacity.
Education and human development.
Work transition in the AI era.
Community resilience and belonging.
Tools that improve agency, dignity, access and trust.
We are especially interested where the founder has lived proximity to the problem and AI or emerging technology meaningfully changes what is possible.
How it works
A lighter way to start.
Infectious is not beginning with a heavy fund structure. The first version is a trusted co-investment and founder-support model.
Founder pipeline
Marc identifies and supports founders with unusual lived insight and high potential.
Aligned capital
Trusted investors, angels, patrons and funds provide cheque-writing capacity.
Co-investment
Deals are structured alongside experienced investors rather than forcing Infectious to carry the full fund-management burden too early.
Founder support
Marc stays close to founders as a coach, connector, storyteller, strategist and human ally.
Track record
Over time, Infectious builds evidence through sourced deals, supported founders, co-investor relationships and outcomes.
For Founders
For founders who are tired of sanding down the soul of the work.
You may be building something because you have lived close to the problem. You may not fit the usual venture pattern. You may be tired of investors asking you to chase vanity metrics or performative growth that makes the company look better while making the mission worse.
We cannot promise investment. We can promise a different kind of conversation.
For Investors
For investors who know founder trust is an edge.
Many great founders do not show up neatly packaged for traditional venture. They need investors who can see the human signal before it becomes obvious market data.
Marc brings founder access, support, network and narrative. You bring capital, structuring, diligence and investment discipline.
Founder Care
Founder care is part of investment performance.
Founders are not assets to be extracted. They are humans carrying risk, pressure, belief and uncertainty.
Investors who care about founders as whole people earn more trust, earlier access, better truth and deeper loyalty. That does not mean avoiding hard commercial judgement. It means bringing humanity, clarity and courage to the investment relationship.
The best founders do not need more spreadsheet cosplay. They need capital that understands what they are really building.
The Infectious edge
Marc finds founder signal early.
Marc Winn has spent years working at the intersection of purpose, community, technology, innovation and human potential. His Ikigai work spread globally because it gave language to something people already felt. That same instinct sits at the heart of Infectious.
Marc's role is not to be a traditional fund manager. It is to find founder signal early, understand the deeper human truth behind the company, help founders articulate the work, connect them to the right people, and support them through the messy reality of building.
Build with us
Help build the cheque-writing layer.
The first goal is not to build a fund. The first goal is to prove the signal — with a small group of investors, angels, family offices or patrons willing to create the early cheque-writing capacity around the Infectious pipeline.